Search results
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 16 hours agoBlueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript May 2, 2024 Blueprint...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 3 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA TODAY Opinion via Yahoo News· 3 days agoFDA approval may help burst Big Pharma myths. Making it easier for patients to take their medicines...
Florida Blue Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 12 hours agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Florida Blue...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 2 days agoSales of Tyvaso DPI were driven by higher volumes and increased commercialization utilization of the...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 2 days agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
Q1 2024 Blueprint Medicines Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoImportantly, unlike last year, we expect these patients will be able to stay on therapy for the rest of the year due to changes to the out-of-pocket cap as part of Medicare